GZR4 - Business-News-Today.com

🚀 Building a website? Start with reliable WordPress hosting from MilesWeb →

Business news, market intelligence, and global industry analysis.

The Latest

Baltic Classifieds Group (LSE: BCG) rebounds after FY26 sell-off as buyback-fuelled debt swing tests the Baltic monopoly thesis

India charges Hafiz Saeed over Pahalgam attack as Pakistan accountability test deepens

Russia attacks Kyiv with 68 missiles and 351 drones as Patriot stocks run low

Ocado Group (LSE: OCDO) sets 2028 handover date for founder CEO Tim Steiner as board formalises succession runway

Read More

Healthcare Industry News

Gan & Lee Pharmaceuticals reveals competitive Phase 2 results for bofanglutide and GZR4 at ADA 2025 sessions

Gan & Lee Pharmaceuticals presented strong Phase 2 results for bofanglutide and GZR4 in type 2 diabetes, advancing its long-acting diabetes pipeline.

byPallavi Madhiraju

June 21, 2025

web analytics